 Home > Biochemistry News > Biotechnology News > Notice of the Second AI Drug Research and Development Conference

Notice of the Second AI Drug Research and Development Conference

 Last Update: 2022-08-30
 Source: Internet
 Author: User

Tags

synthesis science definition

parkinson's research foundation

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

The 2nd AI Drug R&D Conference and AI Intellectual Medicine Helps Health China Theme Summit

2022.
8.
10-11 China.
Shanghai

Sponsor:
Co-organizer:
Supporting Unit:

Invitation Speech The 2nd AI Drug R&D Conference and AI Intelligent Medicine Helps Health China Theme Summit August 10-11, 2022 China·Shanghai Conference Scale

Main Forum: AI Intelligent Medicine Helps Healthy China
2022. 8. 10 Morning Chairman/Moderator: Ma Jianjingtai Technology Co-founder/CEO
08:15-08:30	Opening speech
08:30-09:05	AI Empowers Biomedicine Pan Yi, School of Computer Science and Control Engineering, Shenzhen Institute of Technology, Chinese Academy of Sciences; Academician of American Academy of Medical and Biological Engineering
09:05-09:40	Artificial Intelligence Assists New Drug Design and Large-Scale Virtual Screening
09:40-10:15	Artificial Intelligence Prediction and Design of Proteins Xu Jinbo Visiting Professor of Tsinghua University; Professor of Toyota Computing Technology Institute in Chicago, USA; Visiting Professor of Peking University; Chief Scientist of Beijing Molecular Heart Technology Co. , Ltd.
10:15-10:30	coffee break
10:30-11:05	AI technology helps China's original innovative drug research and development Ma Jian Co-founder/CEO of Jingtai Technology
11:05-11:40	"Data-Driven Protein Design: Creating a Closed Loop of Computation and Experimentation" Liu Haiyan, Professor, Department of Life Sciences and Medicine, University of Science and Technology of China
11:40-12:15	Roundtable Discussion: Technology Integration and Industrial Upgrade of AI Drug R&D Moderator: Ma Jianjingtai Technology Co-founder/CEO Guest: Pan Yi, Shenzhen Institute of Computer Science and Control Engineering, Chinese Academy of Sciences; Du Guanhua, Academician of American Academy of Medical and Biological Engineering , Chinese Academy of Medical Sciences; Deputy Dean of Institute of Pharmaceutical Sciences, Peking Union Medical College; Director of Drug Screening Center Xu Jinbo Visiting Professor of Tsinghua University; Professor of Toyota Computing Technology Institute in Chicago, USA; Visiting Professor of Peking University; Chief Scientist of Beijing Molecular Heart Technology Co. , Ltd. Ma Jianjingtai Technology Co-founder /CEO Liu Haiyan Professor, Department of Life Science and Medicine, University of Science and Technology of China
12:15-13:10	lunch break

Sub-forum 1: AI Boosts the R&D of Innovative Drugs
2022. 8. 10 Afternoon Chairman/Moderator: Dai Weiguo, Chairman of Monroe Biology; Former President of SAPA Headquarters
13:10-13:45	"Small Molecule Drug AI Automated Synthesis Platform" Zeng Zhuo, CEO of Suzhou Woshi Digital Technology Co. , Ltd.
13:45-14:20	"Application case of artificial intelligence in protein design and peptide drug development" Dong Minghui, CTO of Xi'an Longteng Jingyun Biotechnology Co. , Ltd.
14:20-14:55	"AI Helps Innovative Drug Discovery" Niu Zhangming Founder/CEO of Hangzhou Derui Pharmaceutical Technology Co. , Ltd.
14:55-15:10	coffee break
15:10-15:45	"AI + Molecular Simulation to Create a New Generation of Open Platform for Drug Design" Sun Weijie Co-founder/CEO of Beijing Shenshi Technology Co. , Ltd.
15:45-16:20	"AI + Multi-omics, Efficiently Empowering Drug Innovation and Development" Wen Wen Founder/CEO of Shanghai Huanyi Biotechnology Co. , Ltd.
16:20-16:55	Roundtable Discussion: Exploring New Ways of Cooperation between AI and Pharmaceutical Companies Moderator: Li Miaozhu, Investment Director of China Construction Capital , Guest: Gong Zhen Hansen Pharmaceutical Computational Chemistry Director/Director Zeng Zhuo, CEO of Suzhou Woshi Digital Technology Co. , Ltd. Niu Zhangming, Hangzhou Derui Medicine Founder/CEO of Technology Co. , Ltd. Sun Weijie Co-founder/CEO of Beijing Shenshi Technology Co. , Ltd. Wen Wen Founder/CEO of Shanghai Huanyi Biotechnology Co. , Ltd.

2022. 8. 11 Morning Chairman/Moderator: Gao Yushiyu Capital Investment Director; Head of Strategic Development of Suzhou Puhe Pharmaceuticals
08:30-09:05	"AI-Powered Small Molecule Drug Discovery Integration Platform" Zhang Hongbo, BD VP, Beijing Wangshi Smart Technology Co. , Ltd.
09:05-09:40	"Application and Practice of AI in Innovative Drug Research and Development" Chen Dong, Project Management and Intellectual Property Director/Partner of Guangzhou Fermion Technology Co. , Ltd.
09:40-10:15	"The Cross-Application of DNA-encoded Compound Libraries and Artificial Intelligence in Drug Discovery" Lu Xiaojie, PI, Shanghai Institute of Materia Medica
10:15-10:30	coffee break
10:30-11:05	"AI Empowers New Drug R&D Case Sharing" Ren Feng Chief Scientific Officer/Head of Drug R&D of Insilico Medicine
11:05-11:40	"Artificial Intelligence New Drug Development and Intelligent Drug Synthesis" Duan Hongliang, Dean of Intelligent Pharmaceutical Research Institute, Zhejiang University of Technology
11:40-12:15	Roundtable Discussion: Strategies for AI Acceleration of Innovative Drugs Moderator: Gao Yushiyu Capital Investment Director; Head of Strategic Development of Suzhou Puhe Pharmaceuticals Guests: Lu Aijun, Senior Director of Kanglong Chemical, Yu Zhengtian Co-founder of Shanghai Yudao Biotechnology Co. , Ltd. Chief Technology Officer Zhang Hongbo BD VP of Beijing Wangshi Smart Technology Co. , Ltd. Ren Feng Chief Scientific Officer/Head of Drug Research and Development of Insilico Medicine Duan Hongliang Dean of Intelligent Pharmaceutical Research Institute of Zhejiang University of Technology
12:15-13:10	lunch break

2022. 8. 11 Afternoon Chairman/Moderator: Wei Shifeng, Chairman of Beijing Luonuoqiangshi Medical Technology
13:10-13:45	"How AI Drives Research and Development of Microecological Drugs: Global Trends and China's Innovation" Tan Yinweijun, CEO of Biotechnology Co. , Ltd.
13:45-14:20	"AI-Driven Drug Delivery and Drug Discovery" Lai Caida CEO/Founder of Hangzhou Jitai Pharmaceutical Technology Co. , Ltd.
14:20-14:55	"QbD's Expectations for AI in Pharmaceutical Preparation and Process Research" Wei Shifeng, Chairman of Beijing Luonuoqiangshi Pharmaceutical Technology
14:55-15:10	coffee break
15:10-15:45	Rational Design and Development of Macromolecular Drugs Based on AI and Biophysics
15:45-16:20	Intelligent Chemical Synthesis Based on Big Data and Automation Founder/Chairman/CEO of Xia Ning Zhihua Technology
16:20-16:55	Roundtable Discussion: Application Scenarios of AI in the Pharmaceutical Industry Moderator: Wei Shifeng, Chairman of Beijing Luonuoqiangshi Medical Technology Guest: Hao Tianlong, Director of Medicinal Chemistry of Yingfei Zhiyao, Wang Haoxun , Early Innovation Cooperation Manager of Johnson & Johnson Asia Pacific Innovation Center, Bing Tiejun and Aisiyi Deputy General Manager of Pu R&D Lai Caida CEO/founder of Hangzhou Jitai Pharmaceutical Technology Co. , Ltd. Chen Hang Co-founder/CEO of Beijing Xingkangyuan Biotechnology Co. , Ltd.
	Closing speech

Sub-forum 2: AI drives clinical intelligence
2022. 8. 10 Afternoon Chairman/Moderator: Li Shaochun, General Manager of IBM Greater China Healthcare and Life Sciences; IBM Inventor
13:10-13:45	"Digital-Intelligence Transformation and Boundless Smart Medicine Ecology" Li Shaochun, General Manager of IBM Greater China Healthcare and Life Sciences; IBM Inventor
13:45-14:20	"Data Intelligence Improves the Efficiency and Quality of Clinical Trials of Drugs and Devices" Xu Jiming Partner/CTO of Yidu Cloud (Beijing) Technology Co. , Ltd. ; CEO of Happy Life Technology (HLT)
14:20-14:55	"The Exploration of AI Helping China's Innovative Drugs to Go Overseas" Ma Xiamiao, Director of Medidata China Strategic Solutions, Dassault Systemes
14:55-15:10	coffee break
15:10-15:45	"Clinical Trial Digital Collaboration Sponsor Innovative Application New Model" Gong Yifan, Head of the Enterprise Division of Weishiyun (Anhui) Medical Information Co. , Ltd.
15:45-16:20	"High-Dimensional Mining of Multi-omics Data" Season Preface Founder/CEO of Purui Benchmark Technology (Beijing) Co. , Ltd.
16:20-16:55	： · ： IBM；IBM · ： Science & Technology Office （）/；（HLT）CEO Medidata （）（）/CEO

2022. 8. 11 /：
08:30-09:05	《》
09:05-09:40	《，》 CEO/CMO
09:40-10:15	《AI》；/
10:15-10:30
10:30-11:05	《AI，》 CIC
11:05-11:40	《》
11:40-12:15	：AI · ： · ： CEO/CMO ；/ CIC
12:15-13:10

: AI，
2022. 8. 11 /： /CEO
13:10-13:45	《AI+》（）AI
13:45-14:20	《AI“”》 /CEO
14:20-14:55	《》（）/CEO
14:55-15:10
15:10-15:45	《AI》
15:45-16:20	《““》 •；
16:20-16:55	Roundtable Discussion: "AI Pharmaceuticals Creates "New Possibilities" for New Drug R&D Moderator: Feng Jianxin, Founder/CEO of Shenzhen Beikun Cloud Computing Co. , Ltd. Guest: Wang Junping Technology (Shenzhen) Co. , Ltd. AI Expert Researcher Li Chengtao Xingyao Liu Zhiguo , founder/CEO of Science and Technology (Beijing) Co. , Ltd. Chief Scientific Officer of Alma Bio, Zhao Yu, Deputy Director of Turing Darwin Laboratory, Institute of Computing Technology, Chinese Academy of Sciences; Co-founder of Zheyuan Technology

Support Media

Contact us hezhengshen@shengjiejituan.
cn +86 150 6123 2737
xiewenbo@shengjiejituan.
cn 195 3425 3007
wangyujia@shengjiejituan.
cn

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.